Changchun High-tech (000661.SZ) subsidiary GenSci's application for domestic production of pharmaceuticals for clinical trials has been accepted.

Zhixin Finance APP reports that Changchun High-tech (000661.SZ) has announced that its subsidiary Changchun Ginseng Pharmaceutical Co., Ltd. (referred to as "Ginseng Pharmaceutical") recently received the "Acceptance Notice" issued by the National Medical Products Administration, and the application for clinical trials of GenSci 145 tablets by Ginseng Pharmaceutical has been accepted.